What is the recommended empirical antibiotic regimen and overall management for subacute bacterial peritonitis, particularly in patients on peritoneal dialysis?

Subacute Bacterial Peritonitis in Peritoneal Dialysis

For patients on peritoneal dialysis presenting with subacute bacterial peritonitis, initiate empirical intraperitoneal antibiotics immediately with a first-generation cephalosporin (cefazolin) or vancomycin for Gram-positive coverage PLUS a third-generation cephalosporin (ceftazidime or cefepime) or aminoglycoside for Gram-negative coverage including Pseudomonas species. 1

Empirical Antibiotic Regimen

The 2022 ISPD guidelines provide the most current framework for PD-associated peritonitis management 1. The empirical regimen must cover both Gram-positive organisms (which account for approximately 60% of cases, predominantly coagulase-negative Staphylococcus and S. aureus) and Gram-negative organisms (approximately 30% of cases, led by E. coli and Klebsiella) 2.

Specific Antibiotic Dosing

Intraperitoneal administration is the preferred route - this is consistently superior to intravenous or oral routes 3. The antibiotics should be administered directly into the peritoneal dialysate.

For Gram-positive coverage, choose ONE:

• Cefazolin (first-generation cephalosporin), OR
• Vancomycin (if MRSA prevalence >10% in your unit or patient has recent MRSA history)

For Gram-negative coverage, choose ONE:

• Third-generation cephalosporin (ceftazidime or cefepime preferred for Pseudomonas coverage), OR
• Aminoglycoside (gentamicin or tobramycin)

Recent large-scale cohort data from 2025 demonstrates no significant difference in mortality, hemodialysis transfer, or subsequent peritonitis rates between cefazolin-based versus vancomycin-based empirical regimens 4. This supports using cefazolin as first-line unless specific risk factors for resistant organisms exist.

Critical Management Steps

Immediate Actions (Within 1 Hour)

1. Obtain peritoneal fluid cultures BEFORE starting antibiotics - Inoculate fluid directly into blood culture bottles at bedside, which increases organism recovery from 37% to 48% compared to traditional solid media 5. Do NOT use swabs for specimen collection.

2. Start empirical antibiotics immediately after obtaining cultures - delays worsen outcomes, particularly in septic patients 6

3. Add antifungal prophylaxis - Oral nystatin should be started concurrently to prevent secondary fungal peritonitis 7

4. Consider adjunctive N-acetylcysteine if using aminoglycosides to mitigate ototoxicity risk 1

Tailoring Therapy Based on Culture Results

Once Gram stain or culture results return (typically 24-48 hours), adjust antibiotics to narrow-spectrum targeted therapy. This reduces C. difficile risk, drug toxicity, and antimicrobial resistance 5.

Duration of treatment: 2-3 weeks depending on the organism identified 7

When to Remove the Catheter

Catheter removal is mandatory for:

• Refractory peritonitis (failure to improve after 5 days of appropriate antibiotics)
• Relapsing peritonitis (same organism within 4 weeks)
• Fungal peritonitis
• Refractory exit site or tunnel infections 7

Temporary hemodialysis support will be required. A new PD catheter may be inserted after complete resolution in selected patients 7.

Risk Factors to Address

Exploratory analysis identifies several parameters associated with peritonitis at diagnosis that warrant attention 2:

• Hypoalbuminemia (OR 0.868) - nutritional optimization is critical
• Anemia (lower hemoglobin, OR 0.956)
• Hypocalcemia (OR 0.137)
• Elevated inflammatory markers (higher WBC and neutrophil percentage)

Common Pitfalls

Avoid these errors:

• Using swabs instead of fluid specimens for cultures
• Inoculating solid media only instead of blood culture bottles
• Delaying antibiotics while awaiting cultures in septic patients
• Continuing empirical broad-spectrum therapy after culture results available
• Failing to add antifungal prophylaxis with antibiotics

Monitoring and Follow-up

Target benchmarks per 2022 ISPD guidelines 1:

• Overall peritonitis rate should be ≤0.40 episodes per year at risk

• 80% of patients should remain peritonitis-free per year

If patient fails to improve within 48-72 hours, reassess for:

• Inadequate source control
• Resistant organisms (adjust based on culture sensitivities)
• Fungal superinfection
• Need for catheter removal

The evidence strongly supports that intermittent dosing may be preferred over continuous administration of antibiotics in the dialysate, though both approaches are effective 3. Local antibiotic resistance patterns should guide empirical choices - if E. coli resistance to your standard regimen exceeds 10-20%, obtain routine cultures even for community-acquired infections 6.